A prospective, multinational, multicenter trial to compare the effects of amlodipine/benazepril to benazepril and hydrochlorothiazide combined on the reduction of cardiovascular morbidity and mortality in patients with high risk hypertension

Trial Profile

A prospective, multinational, multicenter trial to compare the effects of amlodipine/benazepril to benazepril and hydrochlorothiazide combined on the reduction of cardiovascular morbidity and mortality in patients with high risk hypertension

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Dec 2014

At a glance

  • Drugs Amlodipine/benazepril (Primary) ; Benazepril/hydrochlorothiazide
  • Indications Cardiovascular disorders; Hypertension; Kidney disorders; Renal failure
  • Focus Therapeutic Use
  • Acronyms ACCOMPLISH
  • Sponsors Novartis
  • Most Recent Events

    • 30 Aug 2010 A late-breaking analysis reviewing 21 trials, including ACCOMPLISH, was presented at the European Society of Cardiology (ESC) Congress, according to a European Society of Cardiology media release.
    • 01 Jul 2010 Results of a sub-study on effects on 24-hour ambulatory blood pressure were presented in the New England Journal of Medicine, available from http://dx.doi.org/10.1056/nejmc1001410.
    • 29 Jun 2010 A separate analysis in diabetic patients has been published in the Journal of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top